1. Home
  2. MRUS vs ACIW Comparison

MRUS vs ACIW Comparison

Compare MRUS & ACIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • ACIW
  • Stock Information
  • Founded
  • MRUS 2003
  • ACIW 1975
  • Country
  • MRUS Netherlands
  • ACIW United States
  • Employees
  • MRUS N/A
  • ACIW N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • ACIW EDP Services
  • Sector
  • MRUS Health Care
  • ACIW Technology
  • Exchange
  • MRUS Nasdaq
  • ACIW Nasdaq
  • Market Cap
  • MRUS 4.1B
  • ACIW 4.7B
  • IPO Year
  • MRUS 2016
  • ACIW 1995
  • Fundamental
  • Price
  • MRUS $66.83
  • ACIW $46.48
  • Analyst Decision
  • MRUS Strong Buy
  • ACIW Strong Buy
  • Analyst Count
  • MRUS 12
  • ACIW 3
  • Target Price
  • MRUS $91.00
  • ACIW $60.00
  • AVG Volume (30 Days)
  • MRUS 661.7K
  • ACIW 895.4K
  • Earning Date
  • MRUS 08-05-2025
  • ACIW 08-07-2025
  • Dividend Yield
  • MRUS N/A
  • ACIW N/A
  • EPS Growth
  • MRUS N/A
  • ACIW 38.68
  • EPS
  • MRUS N/A
  • ACIW 2.37
  • Revenue
  • MRUS $56,228,000.00
  • ACIW $1,700,613,000.00
  • Revenue This Year
  • MRUS $67.27
  • ACIW $9.20
  • Revenue Next Year
  • MRUS $0.49
  • ACIW $6.84
  • P/E Ratio
  • MRUS N/A
  • ACIW $19.72
  • Revenue Growth
  • MRUS 59.77
  • ACIW 11.22
  • 52 Week Low
  • MRUS $33.19
  • ACIW $40.45
  • 52 Week High
  • MRUS $67.59
  • ACIW $59.71
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 64.93
  • ACIW 59.11
  • Support Level
  • MRUS $63.21
  • ACIW $40.45
  • Resistance Level
  • MRUS $67.59
  • ACIW $47.62
  • Average True Range (ATR)
  • MRUS 2.22
  • ACIW 1.37
  • MACD
  • MRUS -0.27
  • ACIW 0.54
  • Stochastic Oscillator
  • MRUS 97.33
  • ACIW 85.36

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About ACIW ACI Worldwide Inc.

ACI Worldwide Inc develops, markets and installs a portfolio of software products focused on facilitating electronic payments. The firm also leverages its distribution network in the Americas; Europe, the Middle East, and Africa, or EMEA; and Asia-Pacific regions to sell software developed by third parties. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but majority of the revenue is generated in the United States and EMEA regions.

Share on Social Networks: